Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial.
Saved in:
| Title: | Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial. |
|---|---|
| Authors: | Giamarellos-Bourboulis EJ; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Jemec GBE; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark., Prens EP; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands., Riedemann NC; InflaRx GmbH, Jena, Germany., Otto I; InflaRx GmbH, Jena, Germany., Weisman J; Medical Dermatology Specialists, Sandy Springs, Atlanta, GA, USA., Pulka G; Centrum Medyczne All-Med, Krakòw, Poland., Nowicki RJ; Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, University Clinical Centre, Gdańsk, Poland., Kantardjiev V; Dermatology and Venereology Department, Military Medical Academy, Sofia, Bulgaria., Pinter A; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt/Main, Frankfurt/Main, Germany., Thomsen SF; Department of Dermatology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark., Berneman D; University of Cincinnati, Department of Dermatology, Cincinnati, OH, USA., Kanni T; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Alavi A; Department of Dermatology, Mayo Clinic Rochester, Rochester, MN, USA., Breno B; CHU Nantes, Hôtel Dieu, Nantes, France., Gooderham M; SKiN Centre for Dermatology, Peterborough, ON, Canada.; Department of Medicine, Queen's University, Kingston, ON, Canada., Stone M; Shenandoah Medical Center, Shenandoah, IA, USA., Anadkat MJ; Department of Medicine, Division of Dermatology, Washington University, St. Louis, MO, USA., Katoulis A; 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Papakonstantis M; Department of Dermatology, 401 General Military Hospital of Athens, Athens, Greece., Becherel PA; Department of Dermatology, Antony Private Hospital, Antony, France., Szepietowski JC; Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland.; Department of Dermatovenereology, 4th Military Hospital, Wrocław, Poland., van der Zee HH; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands., Zouboulis CC; Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany., Sayed CJ; Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA. |
| Source: | The British journal of dermatology [Br J Dermatol] 2026 Jan 27; Vol. 194 (2), pp. 254-263. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41081529 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Giamarellos-Bourboulis+EJ%22">Giamarellos-Bourboulis EJ</searchLink>; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Jemec+GBE%22">Jemec GBE</searchLink>; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.<br /><searchLink fieldCode="AU" term="%22Prens+EP%22">Prens EP</searchLink>; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Riedemann+NC%22">Riedemann NC</searchLink>; InflaRx GmbH, Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Otto+I%22">Otto I</searchLink>; InflaRx GmbH, Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Weisman+J%22">Weisman J</searchLink>; Medical Dermatology Specialists, Sandy Springs, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Pulka+G%22">Pulka G</searchLink>; Centrum Medyczne All-Med, Krakòw, Poland.<br /><searchLink fieldCode="AU" term="%22Nowicki+RJ%22">Nowicki RJ</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, University Clinical Centre, Gdańsk, Poland.<br /><searchLink fieldCode="AU" term="%22Kantardjiev+V%22">Kantardjiev V</searchLink>; Dermatology and Venereology Department, Military Medical Academy, Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Pinter+A%22">Pinter A</searchLink>; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt/Main, Frankfurt/Main, Germany.<br /><searchLink fieldCode="AU" term="%22Thomsen+SF%22">Thomsen SF</searchLink>; Department of Dermatology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Berneman+D%22">Berneman D</searchLink>; University of Cincinnati, Department of Dermatology, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Kanni+T%22">Kanni T</searchLink>; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Alavi+A%22">Alavi A</searchLink>; Department of Dermatology, Mayo Clinic Rochester, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Breno+B%22">Breno B</searchLink>; CHU Nantes, Hôtel Dieu, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Gooderham+M%22">Gooderham M</searchLink>; SKiN Centre for Dermatology, Peterborough, ON, Canada.; Department of Medicine, Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Stone+M%22">Stone M</searchLink>; Shenandoah Medical Center, Shenandoah, IA, USA.<br /><searchLink fieldCode="AU" term="%22Anadkat+MJ%22">Anadkat MJ</searchLink>; Department of Medicine, Division of Dermatology, Washington University, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Katoulis+A%22">Katoulis A</searchLink>; 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Papakonstantis+M%22">Papakonstantis M</searchLink>; Department of Dermatology, 401 General Military Hospital of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Becherel+PA%22">Becherel PA</searchLink>; Department of Dermatology, Antony Private Hospital, Antony, France.<br /><searchLink fieldCode="AU" term="%22Szepietowski+JC%22">Szepietowski JC</searchLink>; Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland.; Department of Dermatovenereology, 4th Military Hospital, Wrocław, Poland.<br /><searchLink fieldCode="AU" term="%22van+der+Zee+HH%22">van der Zee HH</searchLink>; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zouboulis+CC%22">Zouboulis CC</searchLink>; Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.<br /><searchLink fieldCode="AU" term="%22Sayed+CJ%22">Sayed CJ</searchLink>; Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> [Br J Dermatol] 2026 Jan 27; Vol. 194 (2), pp. 254-263. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0004041 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2133 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070963%22">00070963 </searchLink><i>NLM ISO Abbreviation: </i>Br J Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41081529 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/bjd/ljaf398 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 254 Titles: – TitleFull: Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Giamarellos-Bourboulis EJ – PersonEntity: Name: NameFull: Jemec GBE – PersonEntity: Name: NameFull: Prens EP – PersonEntity: Name: NameFull: Riedemann NC – PersonEntity: Name: NameFull: Otto I – PersonEntity: Name: NameFull: Weisman J – PersonEntity: Name: NameFull: Pulka G – PersonEntity: Name: NameFull: Nowicki RJ – PersonEntity: Name: NameFull: Kantardjiev V – PersonEntity: Name: NameFull: Pinter A – PersonEntity: Name: NameFull: Thomsen SF – PersonEntity: Name: NameFull: Berneman D – PersonEntity: Name: NameFull: Kanni T – PersonEntity: Name: NameFull: Alavi A – PersonEntity: Name: NameFull: Breno B – PersonEntity: Name: NameFull: Gooderham M – PersonEntity: Name: NameFull: Stone M – PersonEntity: Name: NameFull: Anadkat MJ – PersonEntity: Name: NameFull: Katoulis A – PersonEntity: Name: NameFull: Papakonstantis M – PersonEntity: Name: NameFull: Becherel PA – PersonEntity: Name: NameFull: Szepietowski JC – PersonEntity: Name: NameFull: van der Zee HH – PersonEntity: Name: NameFull: Zouboulis CC – PersonEntity: Name: NameFull: Sayed CJ IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 01 Text: 2026 Jan 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1365-2133 Numbering: – Type: volume Value: 194 – Type: issue Value: 2 Titles: – TitleFull: The British journal of dermatology Type: main |
| ResultId | 1 |